DRI HEALTHCARE TRUST (DHT-UN.CA) Stock Overview
TSX:DHT-UN - CA23344H1091
14.17 CAD
+0.07 (+0.5%)
Overall DHT-UN gets a fundamental rating of 5 out of 10. We evaluated DHT-UN against 35 industry peers in the Pharmaceuticals industry. DHT-UN has only an average score on both its financial health and profitability. DHT-UN is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
In the past year DHT-UN was profitable.
In the past year DHT-UN had a positive cash flow from operations.
1.2 Ratios
DHT-UN has a better Return On Assets (0.41%) than 74.29% of its industry peers.
DHT-UN has a Return On Equity of 0.78%. This is in the better half of the industry: DHT-UN outperforms 71.43% of its industry peers.
The Return On Invested Capital of DHT-UN (3.82%) is better than 71.43% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DHT-UN is significantly below the industry average of 7.75%.
The 3 year average ROIC (1.94%) for DHT-UN is below the current ROIC(3.82%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.41% | ||
| ROE | 0.78% | ||
| ROIC | 3.82% |
ROA(3y)4.16%
ROA(5y)N/A
ROE(3y)6.27%
ROE(5y)N/A
ROIC(3y)1.94%
ROIC(5y)N/A
1.3 Margins
DHT-UN has a Profit Margin of 2.11%. This is in the better half of the industry: DHT-UN outperforms 77.14% of its industry peers.
DHT-UN's Operating Margin of 25.45% is amongst the best of the industry. DHT-UN outperforms 91.43% of its industry peers.
In the last couple of years the Operating Margin of DHT-UN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.45% | ||
| PM (TTM) | 2.11% | ||
| GM | N/A |
OM growth 3Y-6.12%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DHT-UN is destroying value.
DHT-UN has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, DHT-UN has a worse debt to assets ratio.
2.2 Solvency
DHT-UN has an Altman-Z score of 1.39. This is a bad value and indicates that DHT-UN is not financially healthy and even has some risk of bankruptcy.
With a decent Altman-Z score value of 1.39, DHT-UN is doing good in the industry, outperforming 80.00% of the companies in the same industry.
DHT-UN has a debt to FCF ratio of 3.05. This is a good value and a sign of high solvency as DHT-UN would need 3.05 years to pay back of all of its debts.
DHT-UN's Debt to FCF ratio of 3.05 is amongst the best of the industry. DHT-UN outperforms 88.57% of its industry peers.
A Debt/Equity ratio of 0.77 indicates that DHT-UN is somewhat dependend on debt financing.
DHT-UN has a worse Debt to Equity ratio (0.77) than 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 3.05 | ||
| Altman-Z | 1.39 |
ROIC/WACC0.43
WACC8.89%
2.3 Liquidity
A Current Ratio of 1.83 indicates that DHT-UN should not have too much problems paying its short term obligations.
DHT-UN has a Current ratio of 1.83. This is comparable to the rest of the industry: DHT-UN outperforms 54.29% of its industry peers.
A Quick Ratio of 1.83 indicates that DHT-UN should not have too much problems paying its short term obligations.
The Quick ratio of DHT-UN (1.83) is better than 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.83 | ||
| Quick Ratio | 1.83 |
3. Growth
3.1 Past
The earnings per share for DHT-UN have decreased strongly by -11.89% in the last year.
DHT-UN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.09% yearly.
The Revenue has grown by 16.24% in the past year. This is quite good.
DHT-UN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 32.25% yearly.
EPS 1Y (TTM)-11.89%
EPS 3Y5.09%
EPS 5YN/A
EPS Q2Q%4.08%
Revenue 1Y (TTM)16.24%
Revenue growth 3Y32.25%
Revenue growth 5YN/A
Sales Q2Q%6.07%
3.2 Future
DHT-UN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.37% yearly.
Based on estimates for the next years, DHT-UN will show a quite strong growth in Revenue. The Revenue will grow by 9.07% on average per year.
EPS Next Y-8.03%
EPS Next 2Y3.2%
EPS Next 3Y6.08%
EPS Next 5Y10.37%
Revenue Next Year10.75%
Revenue Next 2Y5.28%
Revenue Next 3Y3.77%
Revenue Next 5Y9.07%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 6.59, which indicates a rather cheap valuation of DHT-UN.
Compared to the rest of the industry, the Price/Earnings ratio of DHT-UN indicates a rather cheap valuation: DHT-UN is cheaper than 91.43% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of DHT-UN to the average of the S&P500 Index (27.13), we can say DHT-UN is valued rather cheaply.
The Price/Forward Earnings ratio is 6.13, which indicates a rather cheap valuation of DHT-UN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DHT-UN indicates a rather cheap valuation: DHT-UN is cheaper than 91.43% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.76. DHT-UN is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.59 | ||
| Fwd PE | 6.13 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DHT-UN indicates a rather cheap valuation: DHT-UN is cheaper than 85.71% of the companies listed in the same industry.
DHT-UN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DHT-UN is cheaper than 88.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.36 | ||
| EV/EBITDA | 7.7 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.2%
EPS Next 3Y6.08%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.57%, DHT-UN is a good candidate for dividend investing.
DHT-UN's Dividend Yield is rather good when compared to the industry average which is at 3.58. DHT-UN pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, DHT-UN pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.57% |
5.2 History
DHT-UN has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y3.2%
EPS Next 3Y6.08%
TSX:DHT-UN (8/29/2025, 7:00:00 PM)
14.17
+0.07 (+0.5%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners48.39%
Inst Owner ChangeN/A
Ins Owners0.88%
Ins Owner ChangeN/A
Market Cap784.17M
Analysts80
Price Target20.81 (46.86%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.57% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-8.16%
Min EPS beat(2)-21.52%
Max EPS beat(2)5.2%
EPS beat(4)3
Avg EPS beat(4)6.36%
Min EPS beat(4)-21.52%
Max EPS beat(4)39.35%
EPS beat(8)5
Avg EPS beat(8)18.78%
EPS beat(12)7
Avg EPS beat(12)90.93%
EPS beat(16)8
Avg EPS beat(16)66.47%
Revenue beat(2)0
Avg Revenue beat(2)-0.5%
Min Revenue beat(2)-0.64%
Max Revenue beat(2)-0.37%
Revenue beat(4)2
Avg Revenue beat(4)14.3%
Min Revenue beat(4)-0.64%
Max Revenue beat(4)46.19%
Revenue beat(8)5
Avg Revenue beat(8)27.34%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.69%
PT rev (3m)2.07%
EPS NQ rev (1m)16.84%
EPS NQ rev (3m)9.9%
EPS NY rev (1m)-5.08%
EPS NY rev (3m)-5.08%
Revenue NQ rev (1m)2.88%
Revenue NQ rev (3m)3.18%
Revenue NY rev (1m)1.46%
Revenue NY rev (3m)3.32%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.59 | ||
| Fwd PE | 6.13 | ||
| P/S | 4.2 | ||
| P/FCF | 5.36 | ||
| P/OCF | 5.36 | ||
| P/B | 1.56 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.7 |
EPS(TTM)2.15
EY15.17%
EPS(NY)2.31
Fwd EY16.31%
FCF(TTM)2.64
FCFY18.64%
OCF(TTM)2.64
OCFY18.64%
SpS3.37
BVpS9.1
TBVpS-4.89
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.41% | ||
| ROE | 0.78% | ||
| ROCE | 5.31% | ||
| ROIC | 3.82% | ||
| ROICexc | 4.21% | ||
| ROICexgc | 90.74% | ||
| OM | 25.45% | ||
| PM (TTM) | 2.11% | ||
| GM | N/A | ||
| FCFM | 78.26% |
ROA(3y)4.16%
ROA(5y)N/A
ROE(3y)6.27%
ROE(5y)N/A
ROIC(3y)1.94%
ROIC(5y)N/A
ROICexc(3y)2.05%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.74%
ROCE(5y)N/A
ROICexcg growth 3Y44.9%
ROICexcg growth 5YN/A
ROICexc growth 3Y-7.25%
ROICexc growth 5YN/A
OM growth 3Y-6.12%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.19
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 3.05 | ||
| Debt/EBITDA | 2.61 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 97.99% | ||
| Profit Quality | 3716.37% | ||
| Current Ratio | 1.83 | ||
| Quick Ratio | 1.83 | ||
| Altman-Z | 1.39 |
F-Score6
WACC8.89%
ROIC/WACC0.43
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.89%
EPS 3Y5.09%
EPS 5YN/A
EPS Q2Q%4.08%
EPS Next Y-8.03%
EPS Next 2Y3.2%
EPS Next 3Y6.08%
EPS Next 5Y10.37%
Revenue 1Y (TTM)16.24%
Revenue growth 3Y32.25%
Revenue growth 5YN/A
Sales Q2Q%6.07%
Revenue Next Year10.75%
Revenue Next 2Y5.28%
Revenue Next 3Y3.77%
Revenue Next 5Y9.07%
EBIT growth 1Y343.32%
EBIT growth 3Y24.15%
EBIT growth 5YN/A
EBIT Next Year111.01%
EBIT Next 3Y28.63%
EBIT Next 5Y23.32%
FCF growth 1Y103.46%
FCF growth 3Y19.16%
FCF growth 5YN/A
OCF growth 1Y103.46%
OCF growth 3Y19.16%
OCF growth 5YN/A